Research Topics
| Douglas G AltmanSummaryAffiliation: Cancer Research UK Country: UK Publications
| Collaborators
|
Detail Information
Publications
LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impactElie A Akl
Department of Medicine, State University of New York at Buffalo, Buffalo, USA
Trials 10:40. 2009..The secondary objectives are to describe, for published RCTs, (1) the reporting of loss to follow-up information, (2) the analytic methods used for handling loss to follow-up information, and (3) the extent of reported loss to follow-up...
Decision tools in health care: focus on the problem, not the solutionJoseph Liu
Cancer Research UK NHS Centre for Statistics in Medicine, Oxford University, UK
BMC Med Inform Decis Mak 6:4. 2006..The generic term, 'decision tool' (DT), is therefore suggested to demonstrate that these aids, which seem different technically, are conceptually the same from a clinical viewpoint...
Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): study protocolDiana Eccles
Somers Cancer Sciences Building Mail Point 824, Southampton University Hospitals NHS Trust, Tremona Road, Southampton SO16 6YA, UK
BMC Cancer 7:160. 2007..The primary aim of the POSH study is to establish whether genetic status influences the prognosis of primary breast cancer independently of known prognostic factors...
Why we need confidence intervalsDouglas G Altman
NHS Cancer Research UK Centre for Statistics in Medicine, Old Road Campus, Headington, Oxford OX3 7LF, UK
World J Surg 29:554-6. 2005..They are especially useful for avoiding misinterpretation of nonsignificant results of small studies. CIs should be provided routinely for the main results of trials and observational studies...
Commentary: Systematic reviewers face challenges from varied study designsDouglas G Altman
Cancer Research UK Medical Statistics Group, Centre for Statistics in Medicine, Institute of Health Sciences, Oxford OX3 7LF
BMJ 325:461. 2002
[Diagnostic (STARD) and prognostic (REMARK) studies]Douglas G Altman
Centre for Statistics in Medicine, Wolfson College, Oxford, Reino Unido
Med Clin (Barc) 125:49-55. 2005..We describe initiatives to develop reporting guidelines for diagnostic accuracy studies (STARD) and tumour marker prognostic studies (REMARK)...
[Developing guidelines for reporting healthcare research: scientific rationale and procedures]Douglas G Altman
Centre for Statistics in Medicine, Wolfson College, Oxford, Reino Unido
Med Clin (Barc) 125:8-13. 2005..We describe recommended processes to produce guidelines that have evolved over several years during the preparation of a sequence of reporting guidelines including CONSORT, QUOROM, STARD and STROBE...
[Randomization and comparison of final quality in clinical studies]Douglas G Altman
Medical Statistics Laboratory, Imperial Cancer Research Fund, London
Z Arztl Fortbild Qualitatssich 99:629-34. 2005
Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authorsDouglas G Altman
Centre for Statistics in Medicine, Wolfson College, Oxford OX2 6UD
BMJ 330:1056-7. 2005
Primer: an evidence-based approach to prognostic markersDouglas G Altman
Cancer Research UK Medical Statistics Group, Centre for Statistics in Medicine, Wolfson College, Oxford, UK
Nat Clin Pract Oncol 2:466-72. 2005..Prospectively planned pooled analyses of high-quality studies, along with general availability of individual patient data and adherence to reporting guidelines, would help alleviate many of these problems...
Standard deviations and standard errorsDouglas G Altman
Cancer Research UK/NHS Centre for Statistics in Medicine, Wolfson College, Oxford OX2 6UD
BMJ 331:903. 2005
Improving design and analysis of research: lessons from clinical researchDouglas G Altman
Cancer Research UK NHS Centre for Statistics in Medicine, Institute of Health Sciences, Headington, Oxford OX3 7LF, UK
Altern Lab Anim 32:31-9. 2004..Published reviews of the quality of design and analysis in clinical studies are used to see what lessons can be drawn in respect of animal research. The need for clear and full reporting of research is discussed...
Treatment allocation by minimisationDouglas G Altman
Cancer Research UK Medical Statistics Group, Centre for Statistics in Medicine, Oxford OX3 7LF
BMJ 330:843. 2005
Interaction revisited: the difference between two estimatesDouglas G Altman
Cancer Research UK Medical Statistics Group, Centre for Statistics in Medicine, Institute for Health Sciences, Oxford OX3 7LF
BMJ 326:219. 2003
The cost of dichotomising continuous variablesDouglas G Altman
Cancer Research UK/NHS Centre for Statistics in Medicine, Wolfson College, Oxford OX2 6UD
BMJ 332:1080. 2006
Meta-analysis, Simpson's paradox, and the number needed to treatDouglas G Altman
Centre for Statistics in Medicine, Institute of Health Sciences, Old Road, Headington, Oxford, UK
BMC Med Res Methodol 2:3. 2002..There is debate concerning methods for calculating numbers needed to treat (NNT) from results of systematic reviews...
Missing dataDouglas G Altman
Cancer Research UK/NHS Centre for Statistics in Medicine, Oxford OX2 6UD
BMJ 334:424. 2007
Poor-quality medical research: what can journals do?Douglas G Altman
Cancer Research UK NHS Centre for Statistics in Medicine, Institute of Health Sciences, Old Road, Headington, Oxford OX3 7LF, England
JAMA 287:2765-7. 2002..In 1994 I observed that research papers commonly contain methodological errors, report results selectively, and draw unjustified conclusions. Here I revisit the topic and suggest how journal editors can help...
How statistical expertise is used in medical researchDouglas G Altman
Centre for Statistics in Medicine, Cancer Research UK NHS, Institute of Health Sciences, Old Rd, Headington, Oxford OX3 7LF, England
JAMA 287:2817-20. 2002..Investigation of the nature and frequency of statistician involvement in medical research and its relation to the final editorial decision...
Polyp measurement and size categorisation by CT colonography: effect of observer experience in a multi-centre settingDavid Burling
Intestinal Imaging Centre, St. Marks Hospital, London, UK
Eur Radiol 16:1737-44. 2006..e. large polyps misclassified as medium). Caution should be exercised for polyps whose colonographic diameter is below but close to the 1-cm boundary threshold in order to avoid potential miscategorisation of advanced adenomas...
Reporting on covariate adjustment in randomised controlled trials before and after revision of the 2001 CONSORT statement: a literature reviewLy Mee Yu
Centre for Statistics in Medicine, University of Oxford, Wolfson College Annexe, Oxford, UK
Trials 11:59. 2010..To evaluate the use and reporting of adjusted analysis in randomised controlled trials (RCTs) and compare the quality of reporting before and after the revision of the CONSORT Statement in 2001...
The EQUATOR Network and reporting guidelines: Helping to achieve high standards in reporting health research studiesIveta Simera
Centre for Statistics in Medicine, Oxford, UK
Maturitas 63:4-6. 2009....
Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR NetworkIveta Simera
Centre for Statistics in Medicine, University of Oxford, Oxford, UK
BMC Med 8:24. 2010..This paper outlines EQUATOR's goals and activities and offers suggestions for organizations and individuals involved in health research on how to strengthen research reporting...
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaborationDouglas G Altman
Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom
PLoS Med 9:e1001216. 2012..The paper provides a comprehensive overview to educate on good reporting and provide a valuable reference of issues to consider when designing, conducting, and analyzing tumor marker studies and prognostic studies in medicine in general...
Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation studyAndrea Marshall
Centre for Statistics in Medicine, University of Oxford, Oxford, UK
BMC Med Res Methodol 10:7. 2010..Therefore a simulation study was performed to assess the effects of different missing data techniques on the performance of a prognostic model...
Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelinesAndrea Marshall
Centre for Statistics in Medicine, University of Oxford, Oxford, UK
BMC Med Res Methodol 9:57. 2009..However, the normality assumption may not be appropriate for all the parameters of interest when analysing prognostic modelling studies, such as predicted survival probabilities and model performance measures...
Reporting methods in studies developing prognostic models in cancer: a reviewSusan Mallett
Centre for Statistics in Medicine, University of Oxford, Linton Rd, Oxford, UK
BMC Med 8:20. 2010..The reliability of models depends on informed use of statistical methods, in combination with prior knowledge of disease. We reviewed published articles to assess reporting and methods used to develop new prognostic models in cancer...
Reporting of participant flow diagrams in published reports of randomized trialsSally Hopewell
Centre for Statistics in Medicine, University of Oxford, Wolfson College, Linton Road, Oxford, UK
Trials 12:253. 2011..We assessed the type and completeness of information reported in CONSORT (Consolidated Standards of Reporting Trials) flow diagrams published in current reports of randomized trials...
Computed tomographic colonography: assessment of radiologist performance with and without computer-aided detectionSteve Halligan
Department of Specialist Radiology, University College Hospital, London, England
Gastroenterology 131:1690-9. 2006..However, the unavoidable interaction between CAD and the reader has not been addressed...
Guidelines for reporting health research: the EQUATOR network's survey of guideline authorsIveta Simera
Centre for Statistics in Medicine, Oxford, United Kingdom
PLoS Med 5:e139. 2008
Systematic reviews of diagnostic tests in cancer: review of methods and reportingSusan Mallett
Centre for Statistics in Medicine, University of Oxford, Wolfson College, Oxford OX2 6UD
BMJ 333:413. 2006..To assess the methods and reporting of systematic reviews of diagnostic tests...
Comparison of imputation methods for handling missing covariate data when fitting a Cox proportional hazards model: a resampling studyAndrea Marshall
Centre for Statistics in Medicine, University of Oxford, Oxford, UK
BMC Med Res Methodol 10:112. 2010..A resampling study was performed to investigate the effects of different missing data methods on the performance of a prognostic model...
Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journalsAllison Hirst
The EQUATOR Network, Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom
PLoS ONE 7:e35621. 2012..We examined journals' instructions to peer reviewers to see if and how reviewers are encouraged to use them...
Predicting the adverse risk of statin treatment: an independent and external validation of Qstatin risk scores in the UKGary S Collins
Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford, Linton Road, Oxford OX2 6UD, UK
Heart 98:1091-7. 2012..To evaluate the performance of the QStatin scores for predicting the 5-year risk of developing acute renal failure, cataract, liver dysfunction and myopathy in men and women in England and Wales receiving statins...
Reporting clinical research: guidance to encourage accurate and transparent research reportingIveta Simera
Centre for Statistics in Medicine, University of Oxford, Oxford, UK
Maturitas 72:84-7. 2012..equator-network.org)...
The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMedSally Hopewell
Centre for Statistics in Medicine, University of Oxford, Linton Road, Oxford OX2 6UD
BMJ 340:c723. 2010....
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articlesAn Wen Chan
Centre for Statistics in Medicine, Institute of Health Sciences, Headington, Oxford, England
JAMA 291:2457-65. 2004..Selective reporting of outcomes within published studies based on the nature or direction of their results has been widely suspected, but direct evidence of such bias is currently limited to case reports...
Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessedAgnes Dechartres
Centre for Statistics in Medicine, University of Oxford, Oxford, UK
J Clin Epidemiol 64:136-44. 2011..Many reviews specifically aimed to assess the quality of randomized controlled trials (RCTs). We evaluated the quality of reporting in such reviews...
An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort studyGary S Collins
Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford, Oxford OX2 6UD
BMJ 340:c2442. 2010....
Reporting performance of prognostic models in cancer: a reviewSusan Mallett
Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford, Linton Road, Oxford OX2 6UD, UK
BMC Med 8:21. 2010..We reviewed published articles to assess the methods and reporting used to develop and evaluate performance of prognostic indices and risk groups from prognostic models...
Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScoresGary S Collins
Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford, Oxford OX2 6UD, UK
BMJ 342:d3651. 2011..To evaluate the performance of the QFractureScores for predicting the 10 year risk of osteoporotic and hip fractures in an independent UK cohort of patients from general practice records...
Diagnostic tests 4: likelihood ratiosJonathan J Deeks
Screening and Test Evaluation Program, School of Public Health, University of Sydney, NSW 2006, Australia
BMJ 329:168-9. 2004
Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical settingAnne Szarewski
Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Charterhouse Square, London EC1M 6BQ, UK
J Med Screen 14:34-42. 2007..To compare the performance and acceptability of unsupervised self-sampling with clinician sampling for high-risk human papillomavirus (HPV) types for the first time in a UK screening setting...
Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2Gary S Collins
Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford, Oxford OX2 6UD, UK
BMJ 344:e4181. 2012....
Systematic review: bias in imaging studies - the effect of manipulating clinical context, recall bias and reporting intensityDarren Boone
Centre for Medical Imaging, University College London, London, UK
Eur Radiol 22:495-505. 2012..In particular, those which modify or conceal sample characteristics (e.g. disease prevalence or reporting intensity) or research setting ("laboratory" versus "field"). We also investigated recall bias...
EQUATOR: reporting guidelines for health researchDouglas G Altman
Centre for Statistics in Medicine, University of Oxford, Oxford OX2 6UD, UK
Lancet 371:1149-50. 2008
CT colonography interpretation times: effect of reader experience, fatigue, and scan findings in a multi-centre settingDavid Burling
Intestinal Imaging Centre, St. Marks Hospital, London, UK
Eur Radiol 16:1745-9. 2006..Technicians who report more slowly are more accurate. All groups reported faster as the study period progressed...
Responsible reporting of health research studies: transparent, complete, accurate and timelyDouglas G Altman
Centre for Statistics in Medicine, University of Oxford, UK
J Antimicrob Chemother 65:1-3. 2010..equator-network.org). Poor reporting practices can be decreased only through close collaboration of all parties involved in research and its publication; EQUATOR can facilitate the process...
Improving the reporting of randomised trials: the CONSORT Statement and beyondDouglas G Altman
Centre for Statistics in Medicine, University of Oxford, Wolfson College, Linton Road, Oxford, U K
Stat Med 31:2985-97. 2012..We detail the subsequent development and extension of CONSORT and consider related initiatives aimed at improving the reliability of the medical research literature...
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaborationDouglas G Altman
Centre for Statistics in Medicine, University of Oxford, UK
BMC Med 10:51. 2012..In this paper we expand on the REMARK checklist to enhance its use and effectiveness through better understanding of the intent of each item and why the information is important to report...
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)Simon P L Travis
Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK
Gut 61:535-42. 2012..Variability in endoscopic assessment necessitates rigorous investigation of descriptors for scoring severity of ulcerative colitis (UC)...
Ensuring trial validity by data quality assurance and diversification of monitoring methodsColin Baigent
Clinical Trial Service Unit and Epidemiological Studies Unit, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF
Clin Trials 5:49-55. 2008....
No surgical innovation without evaluation: the IDEAL recommendationsPeter McCulloch
Nuffield Department of Surgery, University of Oxford, Oxford, UK
Lancet 374:1105-12. 2009..Achievement of improved design, conduct, and reporting of surgical research will need concerted action by editors, funders of health care and research, regulatory bodies, and professional societies...
The design of simulation studies in medical statisticsAndrea Burton
Cancer Research UK NHS Centre for Statistics in Medicine, Oxford, UK
Stat Med 25:4279-92. 2006..A checklist highlighting the important considerations when designing a simulation study is provided. A small review of the literature identifies the current practices within published simulation studies...
Developing a prognostic model in the presence of missing data: an ovarian cancer case studyTaane G Clark
Centre for Statistics in Medicine, Institute of Health Sciences, University of Oxford, Old Road, Oxford OX3 7LF, United Kingdom
J Clin Epidemiol 56:28-37. 2003..This will increase the power of an analysis and may produce models that are more statistically reliable and applicable within clinical practice...
Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomesIsabelle Boutron
Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom
JAMA 303:2058-64. 2010..Previous studies indicate that the interpretation of trial results can be distorted by authors of published reports...
The Oxford Conception Study design and recruitment experienceCecilia Pyper
National Perinatal Epidemiology Unit, University of Oxford, Oxford, UK
Paediatr Perinat Epidemiol 20:51-9. 2006..In addition to presenting the study design, we review the recruitment experience for the Oxford Conception Study. We have achieved sustained and effective recruitment over time by primary use of recruiting via the Internet...
Agreed statistics: measurement method comparisonJ Martin Bland
Department of Health Sciences, University of York, Heslington, York, United Kingdom
Anesthesiology 116:182-5. 2012..The use of correlation is misleading. An alternative approach, based on graphical techniques and simple calculations, is described, together with the relation between this analysis and the assessment of repeatability...
CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reportingSteve Halligan
Department of Specialist Radiology, University College Hospital, Euston Rd, London, NW1 2BU, England
Radiology 237:893-904. 2005..Studies are poorly reported, however, and the authors propose a minimum data set for study reporting...
An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort studyGary S Collins
Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford, Oxford OX2 6UD
BMJ 339:b2584. 2009..To independently evaluate the performance of the QRISK score for predicting 10 year risk of cardiovascular disease in an independent UK cohort of patients from general practice and compare the performance with Framingham equations...
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfallsStuart J Pocock
Medical Statistics Unit, London School of Hygiene and Tropical Medicine, WC1E 7HT, London, UK
Lancet 359:1686-9. 2002....
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesErik von Elm
Institute of Social and Preventive Medicine ISPM, University of Bern, Finkenhubelweg 11, CH 3012 Bern, Switzerland
Prev Med 45:247-51. 2007..We hope that the STROBE Statement will contribute to improving the quality of reporting of observational studies...
Reporting on statistical methods to adjust for confounding: a cross-sectional surveyMarcus Mullner
Universitätsklinik für Notfallmedizin, Allgemeines Krankenhaus Wien, Währinger Gürtel 18 20 6D, A 1090 Vienna, Austria
Ann Intern Med 136:122-6. 2002..The use of complex statistical models to adjust for confounding is common in medical research...
Improving the completeness and transparency of reports of randomized trials in oral health: the CONSORT statementIan Needleman
International Centre for Evidence Based Oral Health, Unit of Periodontology, UCL Eastman Dental Institute, 256 Gray s Inn Road, London WC1X 8LD, United Kingdom
Am J Dent 21:7-12. 2008..A systematic review has shown that the quality of reporting of trials improves in journals that have adopted this guidance, although with significant variation, most likely due to differing levels of editorial adherence to it...
Agreement between methods of measurement with multiple observations per individualJ Martin Bland
Department of Health Sciences, University of York, York, UK
J Biopharm Stat 17:571-82. 2007..In this paper we describe methods for analysing such clustered observations, both when the underlying quantity is assumed to be changing and when it is not...
Identification of clinically useful cancer prognostic factors: what are we missing?Lisa M McShane
J Natl Cancer Inst 97:1023-5. 2005
Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scalesDouglas G Altman
Stat Med 24:2733-42; author reply 2743. 2005..Conflating what Bayes actually offers to meta-analysts-a means of converting likelihood functions to credibility intervals-with the use of likelihood functions themselves to summarize, contrast and combine studies is at best misleading...
[Selective reporting of positive outcomes in randomised trials--secondary publication.. A comparison of protocols with published reports]Asbjørn Hróbjartsson
H S Rigshopitalet, Det Nordiske Cochrane Center, University Health Network Toronto, Department of Medicine
Ugeskr Laeger 167:3189-91. 2005..Selective reporting of positive outcomes is associated with bias...
Reporting recommendations for tumor marker prognostic studies (REMARK)Lisa M McShane
Biometric Research Branch, National Cancer Institute, Executive Plaza North, 6130 Executive Blvd, Bethesda, MD 20892 7434, USA
J Natl Cancer Inst 97:1180-4. 2005....
Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomesFrancois Curtin
Medical Statistics Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1 7HT, UK
Stat Med 21:2145-59. 2002..As its computation is similar in cross-over and parallel trials, it is the method of choice to pool results from parallel and cross-over trials in a combined design meta-analysis...
REporting recommendations for tumour MARKer prognostic studies (REMARK)Lisa M McShane
National Cancer Institute, Biometric Research Branch, DCTD, Room 8126, Executive Plaza North, MSC 7434, 6130 Executive Boulevard, Bethesda, MD 20892 7434, USA
Eur J Cancer 41:1690-6. 2005....
Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-overFrancois Curtin
Medical Statistics Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1 7HT, UK
Stat Med 21:2161-73. 2002....
Better reporting of harms in randomized trials: an extension of the CONSORT statementJohn P A Ioannidis
University of Ioannina School of Medicine and Biomedical Research Institute, Foundation for Research and Technology-Hellas, Ioannina, Greece
Ann Intern Med 141:781-8. 2004..Better reporting will help readers critically appraise and interpret trial results. Journals can support this goal by revising Instructions to Authors so that they refer authors to this document...
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analysesFujian Song
Department of Public Health and Epidemiology, University of Birmingham, Birmingham B15 2TT
BMJ 326:472. 2003..To determine the validity of adjusted indirect comparisons by using data from published meta-analyses of randomised trials...
Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyondDavid Moher
Chalmers Research Group, Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Ottawa, Ontario K1H 8L1, Canada
CMAJ 171:349-50. 2004
Analysis and reporting of factorial trials: a systematic reviewFinlay A McAlister
Division of General Internal Medicine, University of Alberta, Edmonton, Canada
JAMA 289:2545-53. 2003....
REporting recommendations for tumor MARKer prognostic studies (REMARK)Lisa M McShane
National Cancer Institute, Biometric Research Branch, DCTD, Room 8126, Executive Plaza North, MSC 7434, 6130 Executive Boulevard, Bethesda, MD 20892 7434, USA
Nat Clin Pract Oncol 2:416-22. 2005....
Dichotomizing continuous predictors in multiple regression: a bad ideaPatrick Royston
MRC Clinical Trials Unit, 222 Euston Road, London NW1 2DA, UK
Stat Med 25:127-41. 2006..Dichotomization of continuous data is unnecessary for statistical analysis and in particular should not be applied to explanatory variables in regression models...
Evidence-based practice in radiology: steps 3 and 4--appraise and apply systematic reviews and meta-analysesSteve Halligan
Department of Specialist Radiology, University College Hospital, Podium Level 2, 235 Euston Rd, London NW1 2BU, England
Radiology 243:13-27. 2007..They also explain how systematic review can help guide methodologic development for future research...
Epidemiology and reporting characteristics of systematic reviewsDavid Moher
Chalmers Research Group, Children s Hospital of Eastern Ontario Research Institute, Ottawa, Canada
PLoS Med 4:e78. 2007..We set out to capture a representative cross-sectional sample of published SRs and examine them in terms of a broad range of epidemiological, descriptive, and reporting characteristics, including emerging aspects not previously examined...
Meta-analyses involving cross-over trials: methodological issuesDiana R Elbourne
Medical Statistics Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK
Int J Epidemiol 31:140-9. 2002..This paper concentrates on RCTs of a different design-two-period, two-treatment cross-over trials...
Quantification of the completeness of follow-upTaane G Clark
Lancet 359:1309-10. 2002..Our measure is easy to calculate, can be illustrated pictorially, and can be used to identify subgroups with especially poor follow-up...
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trialsDavid Moher
Thomas C Chalmers Centre for Systematic Reviews, University of Ottawa, Ottawa, Ontario, Canada
Clin Oral Investig 7:2-7. 2003..In sum, the CONSORT statement is intended to improve the reporting of an RCT, enabling readers to understand a trial's conduct and to assess the validity of its results...
Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' researchJonathan A C Sterne
MRC Health Services Research Collaboration, Department of Social Medicine, University of Bristol, UK
Stat Med 21:1513-24. 2002..We show that both within- and between meta-analysis heterogeneity may be of importance in the analysis of meta-epidemiological studies, and that confounding exists between the effects of publication status and trial quality...
Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomesFrancois Curtin
Medical Statistics Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1 7HT, UK
Stat Med 21:2131-44. 2002..Differences in the weight estimation between WMD and SWMD can also accentuate the relative weight of cross-over trials, which must be considered a case of design-specific bias...
REporting recommendations for tumor MARKer prognostic studies (REMARK)Lisa M McShane
Biometric Research Branch, DCTD, National Cancer Institute, Room 8126, Executive Plaza North, 6130 Executive Boulevard, Bethesda, MD 20892 7434, USA
Breast Cancer Res Treat 100:229-35. 2006....
Reporting recommendations for tumor marker prognostic studiesLisa M McShane
Biometric Research Branch, National Cancer Institute, Bethesda, MD, USA
J Clin Oncol 23:9067-72. 2005
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statementGilda Piaggio
Statistics and Informatics Services Group, Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
JAMA 295:1152-60. 2006..The intent is to improve reporting of noninferiority and equivalence trials, enabling readers to assess the validity of their results and conclusions...
REporting recommendations for tumor MARKer prognostic studies (REMARK)Lisa M McShane
National Cancer Institute, Biometric Research Branch, Bethesda, MD 20892 7434, USA
Nat Clin Pract Urol 2:416-22. 2005....
Guidelines for the design and statistical analysis of experiments using laboratory animalsMichael F W Festing
MRC Toxicology Unit, University of Leicester, UK
ILAR J 43:244-58. 2002....
Peer review of statistics in medical research. Reporting power calculations is importantDouglas G Altman
BMJ 325:491; author reply 491. 2002
Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health ResearchAn Wen Chan
Randomized Controlled Trials Unit, Canadian Institutes of Health Research, Ottawa, Ont
CMAJ 171:735-40. 2004..We sought to determine whether outcome reporting bias would be present in a cohort of government-funded trials subjected to rigorous peer review...
Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatmentsIsabelle Boutron
INSERM U738, AP HP, Hopital Bichat Claude Bernard, and Université Paris 7 Denis Diderot, Paris, France
Ann Intern Med 148:W60-6. 2008..The conduct of randomized, controlled trials of nonpharmacologic treatments presents specific challenges that are not adequately addressed in trial reports...
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaborationIsabelle Boutron
INSERM U738, AP HP, Hopital Bichat Claude Bernard, and Université Paris 7 Denis Diderot, Paris, France
Ann Intern Med 148:295-309. 2008..This extension, in conjunction with the main CONSORT Statement and other CONSORT extensions, should help to improve the reporting of RCTs performed in this field...
From submission to publication: a retrospective review of the tables and figures in a cohort of randomized controlled trials submitted to the British Medical JournalDavid L Schriger
University of California, Los Angeles Emergency Medicine Center, Los Angeles, CA University of California, Los Angeles School of Medicine, Los Angeles, CA, USA
Ann Emerg Med 48:750-6, 756.e1-21. 2006..We investigate how the peer review process affected table and figure quality...
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic reviewAmy C Plint
Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada
Med J Aust 185:263-7. 2006..To determine whether the adoption of the CONSORT checklist is associated with improvement in the quality of reporting of randomised controlled trials (RCTs)...
[The CONSORT statenent: Revised Recommendations For Improving the Quality of Reports of Parallel-Group Randomized Trials]David Moher
Zhongguo Zhong Xi Yi Jie He Za Zhi 25:658-61. 2005
Prognosis research: toward evidence-based results and a Cochrane methods groupRichard D Riley
J Clin Epidemiol 60:863-5; author reply 865-6. 2007
Unjustified restrictions on letters to the editorDouglas G Altman
PLoS Med 2:e126; discussion e152. 2005
Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authorsAn Wen Chan
University Health Network, Department of Medicine, Suite RFE 3 805, 190 Elizabeth Street, Toronto, ON M5G 2C4, Canada
BMJ 330:753. 2005..To examine the extent and nature of outcome reporting bias in a broad cohort of published randomised trials...
The landscape and lexicon of blinding in randomized trialsKenneth F Schulz
Family Health International, Box 13950, Research Triangle Park, NC 27709, USA
Ann Intern Med 136:254-9. 2002
